As part of its continued commitment to developing next-generation cancer therapeutics, Ocean Biomedical is initiating ...
Regeneron UK Limited today announced that the Scottish Medicines Consortium (SMC) has accepted Libtayo® (cemiplimab) for use on the National Health Service as a second-line monotherapy treatment for ...
Police are searching for a suspect after an argument at a Texarkana apartment complex led to a shooting that injured two people Saturday evening. | Ktalnews.com ...
1 天
The Brighterside of News on MSNRevolutionary new cancer treatment destroys tumors in less than 6 daysResearchers from Rice University and Baylor College of Medicine have developed a new treatment that eliminates advanced-stage ...
CStone Pharmaceuticals ("CStone", HKEX: 2616), an innovation-driven biopharmaceutical company focused on the research and development of anti-cancer therapies, today announced that its key product, ...
The home of media agent Jay Sures was vandalized by a group of anti-Israel protesters on Wednesday, who plastered his garage doors with red handprints and strung yellow caution tape throughout his ...
The Norman Police Department posted to social media that a 1-year-old child, who was found walking alone Saturday morning, has been identified and the parent has been located.
研究人员从常见的姜、蒜、芦荟和柠檬中提取出了植物源纳米颗粒(PNP),并发现其包含Nano10和ELN两种不同类型。体外和体内实验均表明,PNP能够被肠道细菌摄取。在众多的肠道细菌中,Lachnospiraceae、Bacteroidaceae等细菌家族在摄取PNP的过程中表现得尤为活跃,是主要的摄取菌。而且,PNP的摄取效率并非一成不变,它会受到PNP类型、植物来源以及肠道微环境等多种因素的影响 ...
NEW YORK – Immuneering on Thursday said it signed a clinical supply agreement with Regeneron to obtain the anti-PD-1 therapy Libtayo (cemiplimab) for a Phase IIa trial testing Immuneering's MEK ...
() - California Attorney General Rob Bonta issued guidance warning hospitals that withholding “hormone therapies” and “gender-affirming surgeries” from minors are in violation of state law if they ...
National Prayer Breakfast on Thursday, President Donald Trump announced he will sign an executive order to eradicate what he ...
In the ALEXANDRA/IMpassion030 trial, Tecentriq (atezolizumab) added to postoperative chemotherapy was not found to improve ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果